NeuEve
This is a decentralized, single-group, open-label clinical trial evaluating a 12-week regimen of the NeuEve Dryness Treatment Kit (comprising Feminine Moisture Support oral softgels, Bone Support oral capsules, NeuEve Salve vulvar topical cream, NeuEve vaginal suppositories, and NeuEve Multivitamin) in postmenopausal women aged 55-65 who experience vaginal dryness, painful sex, and vaginal itching. The study aims to evaluate the effect of the kit on vaginal symptoms, vaginal pH, vaginal microbiome composition, sexual function, and quality of life over 12 weeks of use.
Exclusion Criteria: Female, aged 55-65 years at the time of consent. Postmenopausal (defined as ≥12 consecutive months without menstrual bleeding, or surgical menopause). Currently experiencing self-reported vaginal dryness, painful sex (dyspareunia), and vaginal itching. Willing and able to use all five products of the NeuEve Dryness Treatment Kit as directed for 12 weeks. Willing to perform at-home vaginal pH testing and at-home vaginal microbiome sample collection. Willing to maintain current diet, sleep schedule, and physical activity level for the duration of the 12-week study. Willing t…
All participants receive the five-component NeuEve Dryness Treatment Kit for 12 weeks: Feminine Moisture Support (1 softgel orally twice daily with meals); Bone Support (1 capsule orally twice daily with meals); NeuEve Salve (dime-sized amount applied topically to the vulva once daily at bedtime); NeuEve Silk Suppository (1 suppository inserted vaginally every other day at bedtime for Weeks 1-4) transitioning to NeuEve Silver Suppository (1 suppository inserted vaginally every 5 days for Weeks 5-12); and NeuEve Multivitamin (3 capsules daily with food, divided equally across the day).